OLMA logo

OLMA
Olema Pharmaceuticals Inc

1,799
Mkt Cap
$1.4B
Volume
1.21M
52W High
$36.26
52W Low
$3.77
PE Ratio
-8.63
OLMA Fundamentals
Price
$16.10
Prev Close
$16.64
Open
$16.64
50D MA
$19.77
Beta
1.01
Avg. Volume
2.37M
EPS (Annual)
-$1.87
P/B
2.74
Rev/Employee
$0.00
$1,673.91
Loading...
Loading...
News
all
press releases
Olema Pharmaceuticals (NASDAQ:OLMA) Raised to "Sell" at Wall Street Zen
Wall Street Zen upgraded shares of Olema Pharmaceuticals from a "strong sell" rating to a "sell" rating in a research note on Saturday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Trading 7.7% Higher - Here's What Happened
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 7.7% - What's Next...
MarketBeat·3d ago
News Placeholder
SG Americas Securities LLC Purchases Shares of 69,382 Olema Pharmaceuticals, Inc. $OLMA
SG Americas Securities LLC bought a new stake in shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with...
MarketBeat·7d ago
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Up 8.4% - Still a Buy?
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Up 8.4% - Here's Why...
MarketBeat·12d ago
News Placeholder
Hennion & Walsh Asset Management Inc. Increases Position in Olema Pharmaceuticals, Inc. $OLMA
Hennion & Walsh Asset Management Inc. increased its holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) by 83.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 447,046 shares of the company's stock after purchas...
MarketBeat·13d ago
News Placeholder
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) have been given an average rating of "Moderate Buy" by the fourteen analysts that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have given a h...
MarketBeat·16d ago
News Placeholder
Wolfe Research Initiates Coverage on Olema Pharmaceuticals (NASDAQ:OLMA)
Wolfe Research started coverage on shares of Olema Pharmaceuticals in a research report on Friday. They issued a "peer perform" rating for the company...
MarketBeat·16d ago
News Placeholder
Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?
Key PointsParadigm Biocapital Advisor increased its stake in Olema Pharmaceuticals by 750,000 shares in Q4 2025...
Nasdaq News: Markets·21d ago
News Placeholder
Jefferies Financial Group Begins Coverage on Olema Pharmaceuticals (NASDAQ:OLMA)
Jefferies Financial Group assumed coverage on Olema Pharmaceuticals in a report on Thursday. They issued a "buy" rating for the company...
MarketBeat·24d ago
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
JPMorgan Chase & Co. lifted their target price on Olema Pharmaceuticals from $55.00 to $58.00 and gave the company an "overweight" rating in a research note on Wednesday...
MarketBeat·25d ago
<
1
2
...
>

Latest OLMA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.